Research
Molecular
BGM1812 exhibits excellent performance in terms of half-life, stability, and solubility.
These properties suggest BGM1812 could be a viable therapeutic option.
StrongSupportsmedium confidence
BGM1812, with excellent performance in terms of half-life, stability, and solubility.
Why this rating
The performance metrics are critical for drug efficacy and are well-supported.
Source
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
Leilei Zong et al. · Journal of Medicinal Chemistry · 2025
otherCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →